Christie Ballantyne, MD, explains how the CORALreef Extension study adds safety exposure and shows LDL-C lowering with oral enlicitide is sustained over time.
|Videos|December 3, 2016
What Is Tuberous Sclerosis Complex and How Does It Relate to Epilepsy?
Elizabeth Thiele, MD, PhD--pediatric neurologist/epileptologist, director, The Carol and James Herscot Center for Children and Adults with TSC, Massachusetts General Hospital--discusses tuberous sclerosis complex.
Advertisement
Elizabeth Thiele, MD, PhD--pediatric neurologist/epileptologist, director, The Carol and James Herscot Center for Children and Adults with TSC, Massachusetts General Hospital--discusses tuberous sclerosis complex.
Advertisement
Related to this article
The glucagon/GLP-1 dual agonist did not raise major adverse cardiovascular event risk in adults with obesity, but GI-related discontinuations were high.
Post hoc AHA 2026 data show the oral GLP-1 receptor agonist lowered systolic blood pressure across hypertension stages, partly beyond weight loss.
Early metformin may curb insulin starts in gestational diabetes, while a separate analysis ties a history of the condition to advanced CKM syndrome.
Pharmacy Times previews enlicitide, survodutide, diet and heart failure risk, and pharmacist-led HF care ahead of the AHA Scientific Sessions in Chicago.
RSV hospitalization raised short-term invasive pneumococcal disease risk, especially among unvaccinated individuals.
Two Kidney Week 2026 posters suggest remnant cholesterol–based markers may help stratify CKD severity and cardiovascular death risk on hemodialysis.
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Understanding Kratom: Pharmacology, Safety, and Regulation
2
FDA Requires Class-Wide GLP-1 RA Labeling Changes for Potential NAION Risk
3
Orforglipron Lowers Systolic BP in ATTAIN-1, ATTAIN-2 Analyses
4
Survodutide Shows Cardiovascular Safety in SYNCHRONIZE-CVOT
5